martes, 13 de noviembre de 2012

National Guideline Clearinghouse | Screening for coronary heart disease with electrocardiography: U.S. Preventive Services Task Force recommendation statement.

full-text ►
National Guideline Clearinghouse | Screening for coronary heart disease with electrocardiography: U.S. Preventive Services Task Force recommendation statement.



Guideline Title
Screening for coronary heart disease with electrocardiography: U.S. Preventive Services Task Force recommendation statement.
 
 
Bibliographic Source(s)
U.S. Preventive Services Task Force. Screening for coronary heart disease with electrocardiography: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2012 Oct 2;157(7):512-18 . [13 references] PubMed External Web Site Policy

Guideline Status
This is the current release of the guideline.
This guideline updates a previous version: Screening for coronary heart disease: recommendation statement. Ann Intern Med 2004 Apr 6;140(7):569-72.


2012 Jul 31. doi: 10.7326/0003-4819-157-7-201210020-00514. [Epub ahead of print]

Screening for Coronary Heart Disease With Electrocardiography: U.S. Preventive Services Task Force Recommendation Statement.

Abstract

DESCRIPTION:

Update of the 2004 U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for coronary heart disease (CHD).

METHODS:

The USPSTF reviewed new evidence on the benefits of screening with electrocardiography (ECG) in asymptomatic adults to reduce the risk for CHD events versus not screening, the effect of identifying high-risk persons on treatment to reduce risk, the accuracy of stratifying individuals into risk categories, and the harms of screening.

RECOMMENDATIONS:

The USPSTF recommends against screening with resting or exercise ECG for the prediction of CHD events in asymptomatic adults at low risk for CHD events (D recommendation).The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG for the prediction of CHD events in asymptomatic adults at intermediate or high risk for CHD events (I statement).

No hay comentarios:

Publicar un comentario